Trade BOLT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bolt Biotherapeutics, Inc. (BOLT) is trading at US$3.47, down 2.47% today as of Sep 21, 14:57 EDT. The company has a market capitalisation of US$7.06M. Over the past 52 weeks, BOLT has traded between US$3.10 and US$7.20. On Syfe you can trade BOLT with $0 commission and add it to your watchlist.
| Previous close | US$3.56 |
|---|---|
| Market cap | US$7.06M |
| 52-week range | US$3.10 – US$7.20 |
| Volume | 249.41K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.
Year: 2021
Bolt Biotherapeutics, Inc. (BOLT) stock is trading at US$3.47, -2.47% from the previous close of US$3.56.
The market cap for Bolt Biotherapeutics, Inc. (BOLT) stock is approximately US$7.06M.
The 52-week high for Bolt Biotherapeutics, Inc. (BOLT) stock is US$7.20.
The 52-week low for Bolt Biotherapeutics, Inc. (BOLT) stock is US$3.10.
Bolt Biotherapeutics, Inc. (BOLT) does not currently pay a dividend.
Stay on top of BOLT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
